Type I diabetic patients (DM-1) with an elevated urinary albumin excretion (UAE430 mg/24 h) have a high cardiovascular risk. However, DM-1 patients with normal UAE have incipient abnormalities of the cardiovascular and nervous systems, such as elevations of blood pressures, increases in arterial stiffness and deterioration of autonomic nervous function. We studied the interrelationships of these abnormalities in normoalbuminuric DM-1 patients. In 76 patients, we performed two cardiovascular reflex tests (deep in-and expiration test (IE test) and lying-to-standing test (LS test)), and determined aortic pulse wave velocity (PWV), local arterial compliances of the common carotid, femoral and brachial arteries, and 24-h blood pressures. The DRRmax value of the LS test was associated with aortic PWV (negatively) and the compliance coefficients of the carotid, femoral and brachial arteries. Per 100-ms increase in DRRmax, pulse wave velocity decreased by 0.39 m/s, compliance coefficients of the carotid, femoral and brachial arteries increased by 0.06, 0.08 and 0.05 mm 2 /kPa, respectively. These associations were independent of age, 24-h mean arterial pressure and 24-h heart rate. Increases in arterial stiffness were associated with increases in 24-h systolic and pulse pressure (per 1 m/s increase in PWV, systolic and pulse pressure increased by 2.1 and 1.7 mmHg, respectively). In normoalbuminuric DM-1 patients, deterioration of autonomic nervous function is associated with an increase in arterial stiffness, which, in turn, was associated with, and may cause, increased systolic and pulse pressure. These findings suggest that preventive strategies targeting autonomic dysfunction may reduce cardiovascular morbidity in diabetes.
Type I diabetic patients (DM-1) with an elevated urinary albumin excretion (UAE430 mg/24 h) have a high cardiovascular risk. However, DM-1 patients with normal UAE have incipient abnormalities of the cardiovascular and nervous systems, such as elevations of blood pressures, increases in arterial stiffness and deterioration of autonomic nervous function. We studied the interrelationships of these abnormalities in normoalbuminuric DM-1 patients. In 76 patients, we performed two cardiovascular reflex tests (deep in-and expiration test (IE test) and lying-to-standing test (LS test)), and determined aortic pulse wave velocity (PWV), local arterial compliances of the common carotid, femoral and brachial arteries, and 24-h blood pressures. The DRRmax value of the LS test was associated with aortic PWV (negatively) and the compliance coefficients of the carotid, femoral and brachial arteries. Per 100-ms increase in DRRmax, pulse wave velocity decreased by 0.39 m/s, compliance coefficients of the carotid, femoral and brachial arteries increased by 0.06, 0.08 and 0.05 mm 2 /kPa, respectively. These associations were independent of age, 24-h mean arterial pressure and 24-h heart rate. Increases in arterial stiffness were associated with increases in 24-h systolic and pulse pressure (per 1 m/s increase in PWV, systolic and pulse pressure increased by 2.1 and 1.7 mmHg, respectively). In normoalbuminuric DM-1 patients, deterioration ofIntroduction Type I diabetic (DM-1) patients have an increased mortality and morbidity risk compared to nondiabetic subjects. In all, 75% percent of total diabetesrelated mortality is due to cardiovascular disease. 1, 2 A urinary albumin excretion (UAE) of 30-300 mg/ 24 h identifies DM-1 patients with a high risk of developing end-stage renal disease and of premature death. 3, 4 Normoalbuminuric DM-1 patients have a lower risk of these complications. However, studies using sophisticated techniques have shown incipient abnormalities of the cardiovascular and nervous systems in these patients. These abnormalities include small elevations of blood pressures, a decreased blood pressure decline during sleep, increases in arterial stiffness and impaired autonomic nervous function. [5] [6] [7] [8] Although these abnormalities might be separate and unrelated consequences of the hyperglycaemic environment, it is plausible that abnormalities of the autonomic nervous system and the cardiovascular system are interrelated.
Since incipient abnormalities might be reversible and thus better accessible for therapeutic interventions, it is important to study early abnormalities and their mutual interrelationships. Previous studies have addressed some combinations of early changes, 8, 10, 13, 14 but not extensively. We hypothesized that incipient neuropathy could influence large artery stiffness by direct effects on large arteries (through effects on tone, on proliferation of smooth muscle cells, and on extracellular matrix composition), as well as by effects on small arteries and arterioles, which might alter pulse wave reflection. Changes in large artery stiffness, for their part, are expected to result in changes in blood pressures, particularly systolic and pulse pressure.
In view of these considerations, we studied early abnormalities of the cardiovascular system in normoalbuminuric DM-1 patients. We focused on the interrelationships among autonomic function, arterial stiffness and arterial blood pressure.
Material and methods
Between January 1994 and January 1996, a crosssectional study in DM-1 patients was performed in the outpatient clinics of the Departments of Medicine of five secondary referral centres: the IJsselland Ziekenhuis in Capelle aan de IJssel, the Sint JansGasthuis in Weert, the De Weverziekenhuis in Heerlen, the Franciscus Ziekenhuis in Roosendaal and the Sint Franciscus Ziekenhuis in Rotterdam. Initial results of ambulatory blood pressure measurements in these DM-1 patients have been published previously.
5 DM-1 was defined as onset of diabetes before the age of 30 and necessity of insulin therapy within 6 months after the onset of the disease. Inclusion criteria were: age o65 years; no pregnancy; body mass index (BMI) o29 kg/m 2 ; absence of a history of clinical atherosclerotic disease; serum creatinine o120 mmol/l; UAE o30 mg/24 h; serum total cholesterol o8 mmol/l and no treatment with antihypertensive drugs. The protocol had been approved by the appropriate medical ethics committees. All included DM-1 patients gave informed consent.
Serum creatinine and cholesterol were determined by routine methods. UAE was determined by use of an immunoturbidimetric technique (Behring, Germany), the median of three 24-h urine collections was used. HbA1c was determined with a high-pressure liquid chromatography technique (normal range, 3.4-6.5%).
Autonomic nervous function
Autonomic function tests were performed before the start of the ambulatory blood pressure monitoring (ABPM). Autonomic function was estimated from two cardiovascular reflex tests: the heart rate variability during deep breathing and the lying-tostanding (LS) test. 15 Execution of these tests and analysis of heart rate variability (HRV) have been described previously. 5 In brief, the deep in-and expiration test (IE test) determines the maximal difference in duration of the RR interval of the ECG during deep inspiration and expiration, and is considered to be an estimate of parasympathetic nervous function. The LS test quantifies first the initial increase in heart rate after standing up by determining the shortening of the RR interval (DRRmax (ms)) of the ECG after this manoeuvre; second, it determines the ratio of the duration of the longest RR interval around the 30th and the shortest RR interval around the 15th heart beat after standing up (RRmax/RRmin ratio or max/min ratio). The DRRmax value reflects both parasympathetic and sympathetic nervous function, whereas the max/ min ratio is determined largely by the peripheral sympathetic nervous function. Classification of normal, borderline or abnormal was carried out using the age-adjusted reference values of Wieling et al. 16 
Determination of arterial stiffness
All subjects refrained from smoking or consuming caffeine for at least 2 h before examination. After 15 min of supine rest in a quiet room with constant temperature of 221C, aortic, right carotid, right femoral and right brachial artery wall properties were measured with a vessel wall movement detector system. 17 This device accurately measures diastolic diameter (D) and changes in diameter during the heart cycle (DD). All measurements were made by the same observer (JJvdH-S). The mean of three consecutive measurements (about 15 heart beats) was taken as the patient's reading. Carotid, femoral and brachial arterial compliances were expressed as a compliance coefficient (CC) and was defined as the compliance per unit of length (L), which is the change in cross-sectional area (DA) per unit of pressure (DP). Likewise, carotid, femoral and brachial arterial distensibilities were expressed as distensibility coefficients (DC), defined as the relative change in cross-sectional area (DA/A) of the vessel per unit of pressure. Simultaneously with the vascular measurements, blood pressure was measured at the left arm, with a semi-automated device (Dinamap; Critikon, Tampa, FL, USA). Brachial pulse pressure was calculated as the mean difference between systolic and diastolic blood pressures of 15 recordings. Pulse pressures at the common carotid and femoral arteries were calculated with a technique that calibrates the distension curves obtained with echo-tracking, assuming that the diastolic and mean blood pressures are constant along the arterial tree. This technique has shown good accuracy. 18 Carotid, femoral and brachial arterial wall properties were calculated using the following equations:
where DP is the local pulse pressure. Distensibility reflects predominantly the elastic properties of the arterial wall, while compliance is a measure of the buffering capacity of the vessel. This method has shown good reproducibility (coefficients of variation of the intraobserver variability about 8, 13 and 15% for the carotid, femoral and brachial arteries, respectively).
17
Pulse wave velocity was estimated by the vessel wall movement detector system by use of the delay time from the ECG-trigger (R-top) to the 10% level of the ascending limb of the distension waveform. The difference between the delay times to the femoral and the carotid artery was used as an estimate of the carotid-femoral transit time (T). The mean of three recordings was taken as the subject's reading. The distances from the sternal notch to the site of measurement of the common carotid artery and femoral artery were measured with a tape measurer. The difference between these two distances was used as an estimate of the length of the carotidofemoral segment (L ao ). 19 The average pulse wave velocity (PWV) in this segment was calculated as PWV ¼ L ao =Tðm=sÞ ð 3Þ
which is an estimate of the stiffness of mainly the descending aorta. 20 This technique has shown good reproducibility (intra-observer coefficient of variation about 14%). 21 PWV is related to arterial distensibility by the formula of Moens-Korteweg:
where r is the blood density.
Ambulatory blood pressure measurements (ABPM)
ABPM was performed with a SpaceLabs 90207 monitor (Spacelabs Inc., Redmond, Washington, USA). Ambulatory blood pressure readings were taken at 15-min intervals from 0700 to 2200 h, and at 20-min intervals from 2200 to 0700 h Results of blood pressure measurements were not displayed by the monitor. ABPM was repeated in patients who had ABPM recordings with more than 25% missing values or more than two missing consecutive hours. All mean blood pressures and heart rates (24-h systolic, 24-h MAP and 24-h diastolic blood pressures, 24-h heart rate and heart rate awake and heart rate asleep) were calculated from hourly averages. The waking period was taken from 1000 till 2000 h, the sleeping period from 0000 to 0600 h (ie, 6 h). This method provides good estimates of blood pressures during the waking and sleeping periods, especially when one has a traditional sleep pattern (ie going to bed in the evening before 0100 h and awaking in the morning before 1000 h). 23, 24 The heart rate decline during sleep was calculated as the difference between the mean heart rate during the waking period (HR awake) and the mean heart rate during the sleeping period (HR asleep). The relative heart rate decline was calculated as: relative heart rate decline (%) ¼ (HR awake minus HR asleep) * 100/HR awake. Pulse pressure was defined as the difference between systolic and diastolic blood pressures.
Statistical analysis
Patient characteristics are given as means (s.d.) or percentages. All parameters used in the analyses normally distributed. We used multiple regression analyses to study the relationship of estimates of arterial stiffness with autonomic nervous function. Aortic PWV and carotid, femoral and brachial artery CC or DC were included as dependent variables, and the IE value, DRRmax value or max/min ratio as independent variables. As both estimates of autonomic nervous function and arterial stiffness are age-dependent, 16 ,25 all analyses were adjusted for age. Next, we explored the mechanisms of the associations (if any) by analysing the associations of arterial diameter and distension with autonomic nervous function.
In addition, we investigated whether arterial stiffness (independent variable) was associated with (and thus a potential contributor to) ambulatory systolic and pulse pressure (dependent variables). These analyses were also adjusted for age. 29 All associations were additionally adjusted for potential confounders, such as 24-h MAP, mean 24-h heart rate, 26, 27 pulse pressure, sex, diabetes duration, body mass index, HbA1c, serum cholesterol and smoking. All testing was two-sided, with Po0.05 considered statistically significant. All statistical analyses were performed with SPSS 11.0.1 for Windows (SPSS Inc., Chicago, IL, USA). Table 1 shows the patient characteristics.
Results
Autonomic nervous function and arterial stiffness (Tables 1 and 2) The IE value and the max/min ratio were not associated with aortic PWV or carotid, femoral and brachial DC and CC (P-values40.2), while the DRRmax value was associated with aortic PWV and carotid, femoral and brachial CC (Table 2) but not DC (data not shown). Additional adjustments for 24-h MAP, 24-h heart rate, brachial pulse pressure, sex, diabetes duration, BMI, HbA1c, serum total cholesterol and smoking did not importantly affect these associations (Table 2 ; data partially shown). Arterial stiffness and 24-h ambulatory systolic blood pressure (Table 3) Linear regression analysis adjusted for age showed that the CCs of the carotid, femoral and brachial arteries (independent variables) were not related to ambulatory systolic blood pressure (data not shown). In contrast, aortic PWV and the DC of the carotid artery were significantly related to 24-h ambulatory systolic blood pressure. After adjusting for 24-h MAP, the relationship of 24-h systolic blood pressure with PWV persisted, whereas the relationship with the DC of the carotid artery did not ( Table 3) . Relationships among blood pressures and the DCs of the femoral and brachial arteries were comparable with those of the DC of the carotid artery (data not shown).
Additional adjustments for sex, diabetes duration, BMI, HbA1c, serum total cholesterol and smoking did not importantly affect these associations (data not shown).
Arterial stiffness as a determinant of 24-h ambulatory pulse pressure (Table 4) Linear regression analysis showed that the CCs of the carotid, femoral and brachial arteries were not related to 24-h ambulatory pulse pressures, whereas the DCs of the femoral and brachial arteries and the PWV showed statistically significant relationships with pulse pressure, independently of age. Additional adjustments for 24-h MAP slightly changed these relationships (Table 4) . Additional adjustments for sex, diabetes duration, BMI, HbA1c, serum total cholesterol and smoking did not importantly affect these associations (data not shown).
Discussion
This study had two major findings. First, in patients with otherwise uncomplicated DM-1, impaired autonomic nervous function was associated with greater arterial stiffness of the aorta and the carotid, femoral and brachial arteries. Second, greater arterial stiffness, in turn, was associated with, and may contribute to, higher systolic and pulse pressure. Taken together, these data show that these subtle abnormalities of the cardiovascular system in DM-1 are interrelated and occur before the onset of microalbuminuria.
The DRRmax value was inversely associated with aortic PWV and positively with the CCs of the carotid, femoral and the brachial arteries, after adjustment for age. This indicates that (incipient) autonomic dysfunction is associated with an increase in arterial stiffness. These data are in concordance with previous studies in DM-1, 13,14 which did not adjust for age. The question arises as to what is cause and effect: does autonomic dysfunction lead to increased arterial stiffness, or conversely does increased arterial stiffness result in impaired autonomic nervous function? On the one hand, greater aortic and carotid wall stiffness may impair baroreceptor (i.e. autonomic) function. 28 On the other hand, cross-sectional studies in DM-1 suggest that impaired autonomic nervous function occurs considerably earlier than, and therefore may contribute to, increased arterial stiffness. 6, 7, 9, 10 Clearly, prospective studies are required to resolve this issue.
The mechanisms by which autonomic nervous function might influence the elastic properties of arteries cannot be derived from the present study. The DRRmax value depends both on parasympathetic and sympathetic nervous function. Parasympathetic autonomic nervous dysfunction is characterized by an increase in heart rate, which can already be found in otherwise uncomplicated DM-1 patients. 5, 29 Increases in heart rate per se result in stiffening of arteries independently of changes in activity of the autonomic nervous system. 26, 27 The relationship between the DRRmax value and the carotid and femoral compliance coefficients appeared partly to be mediated by the heart rate. However, the relationships among the DRRmax value and aortic PWV, and the CC of the brachial artery were not mediated by heart rate. b ¼ regression coefficient (standard error of mean); models as defined in Table 2 .
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Blood vessels are abundantly innervated by sympathetic nerves. To the extent that a decreased DRRmax value is a consequence of sympathetic nervous dysfunction, the relationships observed might be caused by effects of the sympathetic nervous system on the vascular tone of large arteries. In rats and humans, most studies show that sympathetic activity restrains arterial distensibility. 27, [30] [31] [32] However, in humans the opposite has also been reported. 32, 33, 33 In addition, these studies addressed acute modulations of the sympathetic nervous system, whereas in DM-1 patients chronic effects are observed. An acute sympathetic denervation will initially lead to dilation and thus an increase in diameter of large arteries. However, after days to weeks the original tone of the smooth muscle cells will be restored to some extent. 34 Whether this development of intrinsic smooth muscle tone will finally mimic the original situation or whether it stabilizes on a lower or higher level is not known. 31 Analysis of the relationships among autonomic function and the arterial diameter and distension in the present study did not show statistically significant relationships. We hypothesize that the autonomic nervous system exerts its effects on arterial stiffness by influencing both the arterial diameter and the elastic properties of the vessel wall. These issues require further study.
Blood pressure and arterial stiffness are interrelated. 25 In DM-1 patients, an increase in mean blood pressure is associated with decreased arterial compliance and distensibility coefficients. 35 However, an increase in arterial stiffness will lead to a decrease of the distension of the artery during the systole and thereby to an increase in systolic blood pressure. The present study confirms this concept by showing that aortic PWV is positively and the carotid, femoral and brachial DCs are negatively associated with 24-h systolic arterial blood pressure, and that much of these associations could not be explained by variability in 24-h MAP.
In DM-1, an increase in aortic stiffness due to changes in the extracellular matrix is plausible, since the increased formation of advanced glycation products in DM-1 is associated with endothelial dysfunction and diminished arterial elasticity. 36, 37 Such changes depend on age and long-term glycaemic control. A new finding of the present study is that autonomic nervous dysfunction may also contribute to increases in arterial stiffness, and that this is independent of age, diabetes duration, HbA1c and mean arterial blood pressure. 38 In turn, an increase in arterial stiffness leads to elevations of systolic and pulse pressures (Tables 3 and 4 ). These findings were most obvious when aortic PWV was taken as a measure of arterial stiffness, possibly due to the fact that the main buffering capacity of the arterial system is provided by the aorta, the elastic properties of which are the main determinants of the PWV. 39 In conclusion, in otherwise uncomplicated DM-1, impaired autonomic nervous function is associated with greater arterial stiffness of the aorta and the carotid, femoral and brachial arteries. These effects appeared partly mediated by the increase in heart rate due to (incipient) parasympathetic nervous dysfunction, and are not explained by glycaemic control and diabetes duration. Increased arterial b ¼ regression coefficient (standard error of mean); models defined as in Table 2 .
stiffness, in turn, was associated with, and may cause, increased systolic blood pressure and pulse pressure. We hypothesize that additional mechanisms by which the autonomic nervous system exerts its effects on the vessel wall include alterations in vascular tone and the composition of the extracellular matrix of the arteries. Further studies should address the causes of deterioration of autonomic nervous function in diabetes, the mechanisms by which the autonomic nervous system influences arterial stiffness and strategies to prevent these abnormalities.
